Effects of Maitland's Antero-Posterior Versus Lateral Mobilizations on Cardiovascular Responses

Sponsor
Riphah International University (Other)
Overall Status
Recruiting
CT.gov ID
NCT05186584
Collaborator
(none)
62
1
2
4
15.6

Study Details

Study Description

Brief Summary

This study will be a randomized control trial and will be conducted in Polyclinic Hospital Islamabad & Rawal Dental and General Hospital Rawalpindi. A sample of 62 participants will be taken. Patients will be divided into two equal groups of 31 participants in each group, group Randomization will be done through flip coin method. Patients in group A will receive Maitland's antero-posterior Mobilization, while Patients in group B will receive Maitland's lateral mobilizations. 4 sessions of treatment will be given for 2 weeks with interval of 3 days, 4 days and 7 days between 1st & 2nd session, 2nd & 3rd session and 3rd & 4th session, respectively. The outcome measures will be OMRON Automatic Blood Pressure Monitor, Numeric pain rating scale(NPRS) and Global Rating of Change questionare will be measured at baseline and at the end of 4th session. Data will be analyzed by SPSS 25.

Condition or Disease Intervention/Treatment Phase
  • Other: MAITLAND'S ANTEROPOSTERIOR(AP) MOBILIZATION
  • Other: MAITLAND'S LATERAL MOBILIZATION
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
62 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Effects of Maitland's Antero-posterior Versus Lateral Mobilizations on Cardiovascular Responses in Non-Specific Chronic Neck Pain
Actual Study Start Date :
Dec 1, 2021
Anticipated Primary Completion Date :
Apr 1, 2022
Anticipated Study Completion Date :
Apr 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: MAITLAND'S ANTEROPOSTERIOR(AP) MOBILIZATION

Patients in this group will receive Maitland's Antero-Posterior Mobilization.

Other: MAITLAND'S ANTEROPOSTERIOR(AP) MOBILIZATION
Group A will receive the 5 sets of 10 seconds Grade 1 mobilizations with a rate of 15 oscillations each set (total 75 oscillations) for AP mobilizations at most symptomatic segment, with 10 seconds rest between sets. Most symptomatic segment is that segment of cervical spine at which patient will feel greatest pain by palpation. For AP mobilizations, patient will lye supine and therapist will stand by his head. Therapist will make broad contact with the thumb, at the costal process of the vertebrae to be mobilized and spread fingers around adjacent neck for stability. Shoulder will be positioned above the joint being treated. Gentle oscillatory Anteroposterior pressure will be performed by the therapist's arm and trunk.

Experimental: MAITLAND'S LATERAL MOBILIZATION

Patients in this group will receive Maitland's Lateral Mobilization.

Other: MAITLAND'S LATERAL MOBILIZATION
Group B will receive the same sets (i.e. 5 sets of 10 seconds Grade 1 mobilizations with a rate of 15 oscillations each set) for lateral mobilizations at most symptomatic segment, with 10 sec rest between each set. For lateral mobilization, patient will lye supine and therapist will stand by his head. Therapist will place the anterolateral aspect 2nd metacarpophalangeal joint over the lateral aspect of transverse process of most symptomatic segment. Gentle lateral oscillations towards the asymptomatic side will be provided by the therapist.

Outcome Measures

Primary Outcome Measures

  1. OMRON Automatic Blood Pressure Monitor [2 Weeks]

    The Omron is an automatic digital device for professional blood pressure measurement at the upper arm level. It measures BP range of 0-299 mmHg

  2. OMRON Automatic heart rate Monitor [2 Weeks]

    The Omron is an automatic digital device for professional heart rate range of 40 -180 beats/min

  3. Numeric Pain Rating Scale (NPRS) [2 Weeks]

    It is a tool used for measuring intensity of pain. Patient select numeric from (0-10) that reflects his/her pain intensity. The reliability of tool is ICC = 0.67; [0.27 to 0.84])

  4. Global Rating of Change (GROC) [2 Weeks]

    It is a scale commonly used in clinical research, particularly in the musculoskseletal area to measure a patient's improvement or deterioration over time, to determine the effect of an intervention .

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 55 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Participants falling in this category would be recruited into the study.

  • Age 25 to 55 years

  • Pain in neck with no known cause for > 3 months

  • Resting systolic blood pressure between 90 to 139 mmHg

  • resting diastolic blood pressure between 60 to 88 mmHg

  • resting heart rate between 60 to 100 beats/min

  • no prior exposure to antero-posterior and lateral mobilizations

Exclusion Criteria:
  • Participants falling in this category would be excluded from the study.

  • age <25 and >55

  • current smokers

  • history of fainting spells, diabetes mellitus, spinal surgery and whiplash injury( in last 6 months)

  • taking medications for blood thinning, diabetes mellitus

  • having neurologic or cardiovascular disease, radiating pain, cervicogenic headaches

  • movement coordination impairment

  • athletes

  • unable to read and write

Contacts and Locations

Locations

Site City State Country Postal Code
1 Rawal General Hospital Rawalpindi Rawalpindi Punjab Pakistan 44000

Sponsors and Collaborators

  • Riphah International University

Investigators

  • Principal Investigator: Waqar Ahmed Awan, PhD, Riphah International University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Riphah International University
ClinicalTrials.gov Identifier:
NCT05186584
Other Study ID Numbers:
  • Ayesha Afsar
First Posted:
Jan 11, 2022
Last Update Posted:
Apr 18, 2022
Last Verified:
Apr 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Riphah International University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Apr 18, 2022